pcos glp-1 The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials The GLP-1 Revolution: From Diabetes

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Ongoing Monitoring Schedule Starting GLP-1 therapy is the beginning of a monitoring relationship, not a one-time event

The shift from volume-driven to value-driven offers ample opportunities for middle market companies, from growth and expansion to pursuing an exit.

2014;38:e61e63

Campo pioneered research in this field, discovering in the early 1930s that a class of peptides called 'incretins' could promote - cells' insulin release, promoting blood-sugar metabolism, appetite regulation, and subsequent weight loss

We have an obligation to understand the full biology of these drugs, not just the intended effect